Dr. Roberto S. Kalil, MD

Dr. Kalil practices at University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System.

Dr. Kalil's NPI, 1245212554, was assigned on November 14, 2005. Dr. Kalil holds Iowa license 33599.

Dr. Kalil's primary practice is University of Maryland Medical Center, at 22 South Greene Street, Baltimore, MD 21201 in Baltimore City. The practice phone is (410) 328-8667.

Dr. Kalil's primary practice is University of Maryland Medical Center in Baltimore, Maryland, part of University of Maryland Medical System. Dr. Kalil is also affiliated with University of Maryland Medical Center Midtown Campus. The medical group on file is University of Maryland Medical Center Gastroenterology and Hepatology. Dmand AI also links Dr. Kalil to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalil practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kalil's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kalil is licensed in Iowa.

CMS data shows 639 Medicare services from Dr. Kalil across 6 procedure codes in 2024, for 242 Medicare patients. Medicare paid $57,285 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 242 Medicare patients who saw Dr. Kalil in 2024. The largest group is under 65, with 123 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 5.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalil's median patient age at 65, with 40% women.

In 2024, Dr. Kalil wrote 1,194 Medicare Part D claims for 122 patients. 96% of them were for generic drugs. CMS names the drug for 1,054 of them, across 21 drugs with 11 or more claims each, at $25,376 in total drug cost. In 2023, CMS named 1,419 claims across 24 drugs.

Dr. Kalil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalil as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Kalil from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $39.